Last week patent highlights (10-29-09):



1. Cell Death Inhibitor - antioxidant response element activator comprising a macrophage migration inhibitory factor or a modified form thereof
2. Lepidopteran-Active Bacillus Thuringiensis Delta-Endotoxin Compositions and Methods of Use
3. METHODS OF INCREASING CEREBRAL BLOOD FLOW
4. METHODS OF ADMINISTERING PORCINE B-DOMAINLESS FVIII
5. PURIFIED ARABINOGALACTAN-PROTEIN (AGP) COMPOSITION USEFUL IN THE TREATMENT PSORIASIS AND OTHER DISORDERS
6. MULTI-DOMAIN AMPHIPATHIC HELICAL PEPTIDES AND METHODS OF THEIR USE
7. GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF
8. Methods of using motilin homologs - polynucleotides polypeptides and peptide fragments thereof
9. NEURONAL DIFFERENTIATION INHIBITOR PEPTIDE AND USE THEREOF
10. COLLYRIUM FOR DRY EYE - composition for treating dry eye includes eledoisin formulated in an ester form and a phospholipid formulated in a micellar form
11. Piperazine derivatives - This invention relates to novel compounds that are piperazine derivatives, and pharmaceutically acceptable salts thereof
12. Composition Comprising Carbohydrates and Peptides which Comprise Tryptophan
13. DIARYL-CYCLYLALKYL DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
14. Unit Dose Form of Glufosfamide - lyophilized unit dose form containing about 2 g of glufosfamide is useful in treatment of cancer and other
15. METHODS OF ADMINISTERING ANTITUMOR AGENT COMPRISING DEOXYCYTIDINE DERIVATIVE
16. PRODUCT COMPRISING A TRANSDUCTION INHIBITOR OF HETEROTRIMERIC G PROTEIN SIGNALS COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF CANCER
17. IMMUNOREGULATORY AGENT - object of the present invention is to provide an immunoregulatory agent which can be continuously ingested on daily diet and
18. Polysaccharide Extract of Lentinus and Pharmaceutical, Cosmetic or Nutraceutical Compositions Comprising Such an Extract
19. Structure and bioactivity of the polysaccharides and oligomers in medicinal plant Dendrobium huoshanense
20. POLYMERIC ARTIFICIAL TEAR SYSTEM - artificial tear formulations and ophthalmic formulations suitable for drug delivery
21. PROTECTIVE GEL BASED ON CHITOSAN AND OXIDIZED POLYSACCHARIDE
22. METHODS OF PRODUCING MICROPARTICLES - and especially chitin microparticles are disclosed that involve reducing the size of particles using a
23. Sulfoalkyl Ether Cyclodextrin Compositions
24. Physical Mode of Action Pesticide - for application on plants and in soils and methods of manufacture and application
25. Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives
26. PHOSPHORUS DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS
27. Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
28. COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
29. Method of removing ticks from the skin and reducing the risk of bites
30. Compounds - compound which is N-oxy]-1-piperidinyl}butyl)ethanesulfonamide STR00001 and salts thereof
31. COMPOSITIONS AND TREATMENTS OF HEART FAILURE IN NON-HUMAN MAMMAL ANIMALS
32. Method and use of nanoparticles to bind biocides in paints
33. PHARMACEUTICAL FORMULATION OF CLAVULANIC ACID
34. SUBSTITUTED PYRAZOLE DERIVATIVES - novel pyrazole derivative and an androgen receptor antagonist containing the derivative
35. DICARBOXAMIDE DERIVATIVES - The invention is concerned with novel dicarboxamide derivatives of formula STR00001 wherein A, B, R
36. Substituted pyrazole derivatives and use thereof
37. BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME
38. 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof
39. SUBSTITUTED PYRIMIDINE DERIVATIVES - The present application describes substituted pyrimidine compounds of formula STR00001 wherein X, A
40. BENZAMIDE DERIVATIVE OR SALT THEREOF - There is provided a compound having a capsaicin receptor VR1 inhibitory activity and useful as a therapeutic
41. Benzoimidazole compounds - , compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H
42. SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS
43. Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
44. BICYCLOAMINE DERIVATIVES - Compounds represented by formula and pharmaceutically acceptable salts thereof have excellent sodium channel inhibitory
45. FUSED HETEROCYCLIC COMPOUNDS - Certain fused pyrrole- and pyrazole-containing heterocyclic compounds are serotonin modulators useful in the treatment of
46. QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS
47. NOVEL DERIVATIVES OF BENZIMIDAZOLE AND IMIDAZO-PYRIDINE AND THEIR USE AS MEDICAMENTS
48. TREATMENT OF DOWN SYNDROM WITH BENZODIAZEPINE RECEPTOR ANTAGONISTS
49. DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES
50. SPIRO ANTIBIOTIC DERIVATIVES - compounds of formula wherein R
51. HETEROCYCLIC JANUS KINASE 3 INHIBITORS - compound of formula having an excellent JAK3 inhibition activity and being useful as an active ingredient of an
52. COMBINATION CANCER CHEMOTHERAPY - Provided is a method for improving treatment of a neoplastic condition by combining a therapeutically effective amount
53. NOVEL TETRAHYDROPYRIDOTHIOPHENES - Compounds of a certain formula in which Ra and Rb have the meanings indicated in the description
54. QUINOLONE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS
55. 3,4,5-Substituted Piperidines as Renin Inhibitors
56. Non-steroidal progesterone receptor modulators
57. Soluble epoxide hydrolase inhibitors - Disclosed are amide thioamide urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase
58. Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
59. MORPHOLINE DOPAMINE AGONISTS - for compounds of formula , and STR00001 Wherein: A is selected from C--X and N, B is selected from C--Y and N, R
60. SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS
61. THERAPEUTIC COMPOUNDS - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof are disclosed
62. SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS
63. FUSED AZOLE-PYRIMIDINE DERIVATIVES - novel fused azolepyriimidine derivatives processes for preparing them and pharmaceutical preparations containing
64. Pyrimidinyl pyridone inhibitors of kinases
65. PYRIMIDINE DERIVATIVES - The invention concerns pyrimidine derivatives of Formula wherein each of p, R
66. THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-MET AUTOPHOSPHORYLATION INHIBITING POTENCY
67. SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
68. Iminopyridine Derivatives and Use Thereof
69. CYCLYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
70. EP4 Receptor Agonist, Compositions and Methods Thereof
71. THERAPEUTIC COMPOUNDS - Compounds comprising STR00001 or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J
72. Methods and compositions for the treatment of cancers, such as melanomas and gliomas
73. Compounds, Compositions and Methods Comprising Pyridazine Derivatives
74. NOVEL PYRIDAZINE DERIVATIVES AND MEDICINES CONTAINING THE SAME AS EFFECTIVE INGREDIENTS
75. PAINKILLING ASSOCIATION COMPRISING A DIHYDROIMIDAZOPYRAZINE DERIVATIVE
76. USE OF A DIHYDROIMIDAZOPYRAZOINE DERIVATIVE FOR TREATING OR PREVENTING PAIN
77. Novel triazolopyridazines - novel compounds of formula STR00001 wherein the variables are defined as herein
78. NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINYL DERIVATIVE AND ITS MEDICAL USE
79. OXYMETHYLENE ARYL COMPOUNDS AND USES THEREOF
80. QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
81. Combination Therapy for the Treatment of Urinary Frequency, Urinary Urgency and Urinary Incontinence
82. FUNGICIDAL ISOXAZOLIDINES - Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, STR00001
83. AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF
84. COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
85. BENZAZOLE ANALOGUES AND USES THEREOF - compounds of the general formulas and and salts and physiologically functional derivatives thereof
86. PHENANTHRIDINE DERIVATIVES AS BRADYKININ ANTAGONISTS
87. PYRIDO[3,4-B]INDOLES AND METHODS OF USE - This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an
88. DI-T-BUTYLPHENYL PIPERAZINES AS CALCIUM CHANNEL BLOCKERS
89. 2,3,4,9- TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS
90. COMPOUNDS THAT INHIBIT PROTEASE CATHEPSIN S AND HCV REPLICATION
91. N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCER
92. Organic Compounds
93. PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH
94. COMBINATIONS OF CLASS-I SPECIFIC HISTONE DEACETYLASE INHIBITORS WITH PROTEASOME INHIBITORS
95. METHODS FOR INHIBITING CARDIAC PAI-1 - methods of inhibiting cardiac PAI-1 by administering a PAI-1 antagonist
96. INHIBITORS OF FATTY ACID AMIDE HYDROLASE
97. GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
98. ANTIBACTERIAL SMALL MOLECULES AND METHODS FOR THEIR SYNTHESIS
99. Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluor- omethyl)phenyl)urea hydrochloride
100. 3-(DIHYDRO-1H-PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)-4-PROPOXYBENZENESULFONAMIDE DERIVATIVES AND METHODS OF USE
previous page   next page  

Archives

09-04-08  07-02-09  10-16-08  05-28-09  12-25-08  10-01-09  09-11-08  07-09-09  02-26-09  08-13-09  
11-20-08  07-30-09  12-18-08  09-10-09  11-27-08  04-16-09  06-11-09  01-08-09  05-14-09  11-06-08  
08-27-09  09-24-09  10-15-09  06-18-09  09-17-09  03-26-09  01-15-09  10-30-08  06-25-09  12-04-08  
10-08-09  08-06-09  02-19-09  06-04-09  10-23-08  02-12-09  04-23-09  09-25-08  05-21-09  01-29-09  
03-05-09  12-11-08  03-19-09  04-30-09  01-01-09  10-22-09  07-23-09  07-16-09  05-07-09  02-05-09  
03-12-09  10-02-08  04-09-09  09-03-09  08-20-09  04-02-09  10-09-08  11-13-08  01-22-09  08-28-08  
09-18-08  08-21-08